Milad Alucozai

Dr. Milad Alucozai is a distinguished Afghan-American neuroscientist, entrepreneur, and global investor with a robust career spanning nearly two decades across venture capital, private equity, and public markets. Leveraging his deep scientific background, particularly in neuroscience, he has established himself as a key figure in the deep tech investment landscape. His investment thesis is heavily concentrated on transformative technologies within biotech, health tech, and artificial intelligence, where he seeks to back companies poised to disrupt established industries and solve complex problems.

As a Partner at Evolution VC Partners, Dr. Alucozai plays a pivotal role in identifying and nurturing early-stage and growth-stage companies. Evolution VC Partners is known for its strategic investments in high-potential ventures, with typical first checks ranging from $500,000 to $5 million. This range allows the firm to support companies from their initial seed rounds through their Series B funding, providing crucial capital for scaling and product development. His involvement often extends beyond capital, offering strategic guidance and leveraging his extensive network to support portfolio companies.

Dr. Alucozai's personal portfolio, as well as his contributions through Evolution VC Partners, includes a diverse array of innovative companies. Publicly available data indicates his involvement in over a dozen investments, showcasing his active engagement in the venture ecosystem. Beyond his investment activities, he holds operational roles, such as Executive Chairman at Neuvana, demonstrating a hands-on approach to company building. His unique blend of scientific acumen and investment prowess positions him as a valuable partner for founders operating at the intersection of science and technology.